Development of a sensitive GC-C-IRMS method for the analysis of androgens

Biomedical Chromatography

Volumn 27, Issue 2, 2013, Pages 259-266

  Polet, Michael ^a   Van Gansbeke, Wim ^a   Deventer, Koen ^a   Van Eenoo, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Doping control; Gas chromatography ombustion isotope ratio mass spectrometry; Sensitivity; Solvent vent injection

Indexed keywords

BODY FLUIDS; ISOTOPES; MASS SPECTROMETRY; SPECTROMETERS;

ANABOLIC STEROID; CARBON ISOTOPIC COMPOSITION; DOPING ANALYSIS; DOPING CONTROL; GAS CHROMATOGRAPHY COMBUSTION-ISOTOPE RATIO MASS SPECTROMETRY; GAS CHROMATOGRAPHY-OMBUSTION-ISOTOPE RATIO MASS SPECTROMETRY; ISOTOPE-RATIO MASS SPECTROMETRY; SENSITIVITY; SOLVENT VENT INJECTION; TESTOSTERONE;

GAS CHROMATOGRAPHY;

ANDROGEN; SOLVENT;

ARTICLE; DOPING; GAS CHROMATOGRAPHY; GAS CHROMATOGRAPHY COMBUSTION-ISOTOPE RATIO MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; MASS SPECTROMETRY; REPRODUCIBILITY; SENSITIVITY ANALYSIS; URINALYSIS; VALIDATION PROCESS;

EID: 84871982401     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2785     Document Type: Article

References (25)

1. Aguilera R, Becchi M, Casabianca H, Hatton CK, Catlin DH, Starcevic B and Pope HG. Improved method of detection of testosterone abuse by gas chromatography combustion isotope ratio mass spectrometry analysis of urinary steroids. Journal of Mass Spectrometry 1996; 31: 169-176.
2. Aguilera R, Catlin DH, Becchi M, Phillips A, Wang C, Swerdloff RS, Pope HG and Hatton CK. Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols. Journal of Chromatography B 1999; 727: 95-105.
3. Aguilera R, Chapman TE, Starcevic B, Hatton CK and Catlin DH. Performance characteristics of a carbon isotope ratio method for detecting doping with testosterone based on urine diols: Controls and athletes with elevated testosterone/epitestosterone ratios. Clinical Chemistry 2001; 47: 292-300.
4. Bowers LD. Oral dehydroepiandrosterone supplementation can increase the testosterone/epitestosterone ratio. Clinical Chemistry 1999; 45: 295-297.
5. Cawley AT, Kazlauskas R, Trout GJ, Rogerson JH and George AV. Isotopic fractionation of endogenous anabolic androgenic steroids and its relationship to doping control in sports. Journal of Chromatographic Science 2005; 43: 32-38.
6. Cawley A, Collins M, Kazlauskas R, Handelsman DJ, Heywood R, Longworth M and Arenas-Queralt A. Stable isotope ratio profiling of testosterone preparations. Drug Testing and Analysis 2010; 2: 557-567.
7. De Brabanter N, Van Gansbeke W, Geldof L and Van Eenoo P. An improved gas chromatography screening method for doping substances using triple quadrupole mass spectrometry, with an emphasis on quality assurance. Biomedical Chromatography, in press.
8. de la Torre X, Gonzalez JC, Pichini S, Pascual JA and Segura J. C-13/C-12 isotope ratio MS analysis of testosterone, in chemicals and pharmaceutical preparations. Journal of Pharmaceutical and Biomedical Analysis 2001; 24: 645-650.
9. Dehennin L and Matsumoto AM. Long-term administration of testosterone enanthate to normal men - alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. The Journal of Steroid Biochemistry and Molecular Biology 1993; 44: 179-189.
10. Fragkaki AG, Angelis YS, Tsantili-Kakoulidou A, Koupparis M and Georgakopoulos C. Statistical analysis of fragmentation patterns of electron ionization mass spectra of enolized-trimethylsilylated anabolic androgenic steroids. International Journal of Mass Spectrometry 2009; 285: 58-69.
11. Kadi F. Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. British Journal of Pharmacology 2008; 154: 522-528.
12. Kicman AT. Pharmacology of anabolic steroids. British Journal of Pharmacology 2008; 154: 502-521.
13. Pozo OJ, Van Eenoo P, Deventer K and Delbeke FT. Ionization of anabolic steroids by adduct formation in liquid chromatography electrospray mass spectrometry. Journal of Mass Spectrometry 2007; 42: 497-516.
14. Pozo OJ, Van Eenoo P, Deventer K, Grimalt S, Sancho JV, Hernandez F and Delbeke FT. Collision-induced dissociation of 3-keto anabolic steroids and related compounds after electrospray ionization. Considerations for structural elucidation. Rapid Communications in Mass Spectrometry 2008; 22: 4009-4024.
15. Saudan C, Baume N, Mangin P and Saugy M. Urinary analysis of 16(5 alpha)-androsten-3 alpha-ol by gas chromatography/combustion/isotope ratio mass spectrometry: implications in anti-doping analysis. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2004; 810: 157-164.
16. Shackleton CHL, Phillips A, Chang T and Li Y. Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 1997a; 62: 379-387.
17. Shackleton CHL, Roitman E, Phillips A and Chang T. Androstanediol and 5-androstenediol profiling for detecting exogenously administered dihydrotestosterone, epitestosterone, and dehydroepiandrosterone: Potential use in gas chromatography isotope ratio mass spectrometry. Steroids 1997b; 62: 665-673.
18. Ueki M and Okano M. Analysis of exogenous dehydroepiandrosterone excretion in urine by gas chromatography/combustion/isotope ratio mass spectrometry. Rapid Communications in Mass Spectrometry 1999; 13: 2237-2243.
19. Uralets VP and Gillette PA. Over-the-counter anabolic steroids 3-androsten-3, 17-dione; 4-androsten-3 beta, 17 beta-diol; and 19-nor-4-androsten-3, 17-dione: excretion studies in men. Journal of Analytical Toxicology 1999; 23: 357-366.
20. Van Eenoo P, Van Gansbeke W, De Brabanter N, Deventer K and Delbeke FT. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. Journal of Chromatography. A 2011; 1218: 3306-3316.
21. Van Renterghem P. Development of a GC/C/IRMS method - confirmation of a novel steroid profiling approach in doping control. Steroids 2012, in press.
22. WADA. Technical Document: Reporting and Evaluation Guidance for Testosterone, Epitestosterone, T/E Ratio and Other Endogenous Steroids: TD2004EAAS. World Anti-Doping Agency: Montreal, 2004.
23. WADA. 2010 Adverse Analytical Findings and Atypical Findings Reported by Accredited Laboratories. World Anti-Doping Agency: Montreal, 2010.
24. WADA. The 2011 Prohibited List, International Standard. World Anti-Doping Agency: Montreal, 2011a.
25. WADA. Guidelines for the Reporting and Management of Elevated T/E Ratios and Endogenous Steroids Version 2.0 October 2011. World Anti-Doping Agency: Montreal, 2011b.